Pneumococcal conjugate second or third-dose vaccines (PCVc) in Paraguay
Paraguay: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 91.0% in 2025. ◆ Volatile
Latest (2025)
91.0%
Change on year
unchanged
World rank
61st
of 194 countries
All-time high
99.0%
in 2016
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Paraguay, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Paraguay stood at 91.0%.
Compared with earlier readings it is up 1.1% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Paraguay peaked at 99.0% in 2016 and was at its lowest, 0.0%, in 2008.
Paraguay ranks 61st of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Paraguay, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 82.0% | — |
| 2013 | 90.0% | +9.8% |
| 2014 | 86.0% | -4.4% |
| 2015 | 90.0% | +4.7% |
| 2016 | 99.0% | +10.0% |
| 2017 | 93.0% | -6.1% |
| 2018 | 94.0% | +1.1% |
| 2019 | 89.0% | -5.3% |
| 2020 | 82.0% | -7.9% |
| 2021 | 62.0% | -24.4% |
| 2022 | 74.0% | +19.4% |
| 2023 | 77.0% | +4.1% |
| 2024 | 91.0% | +18.2% |
| 2025 | 91.0% | +0.0% |
Paraguay compared with similar countries
- Paraguay's 91.0% is above the median for upper middle income countries, which is 76.0%, 1.2× the median. (57 countries reporting)
- Paraguay's 91.0% is above the median for Latin America & Caribbean, which is 82.5%, 1.1× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 72.3% | 0.0% | 99.0% | 10 |
| 2020s | 79.5% | 62.0% | 91.0% | 6 |
Countries ranked near Paraguay
More health data for Paraguay
- Un projection of annual infant deaths, annual growth rate -2.02 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2374 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,098 deaths per 1,000 people (2090)
- Number of infants who die before age 1 339 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.5252 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0469 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5185 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Paraguay?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Paraguay was 91.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Paraguay?
- The highest recorded value was 99.0% in 2016.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Paraguay?
- The lowest recorded value was 0.0% in 2008.
- How does Paraguay rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Paraguay ranks 61st out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Paraguay?
- Over the last ten years it is up 1.1%. The long-run trend across the full record is volatile.
- Where does this Paraguay data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).